Our Mission

To revolutionize women's pelvic health through biomimetic innovation

Our Story

Founded in 2017 by a team of biomaterials scientists and pelvic surgeons

We recognized a critical gap in women's healthcare: existing solutions for pelvic floor disorders were using outdated materials never designed for dynamic human tissues.

Science-Backed Innovation: Originating from 7 years of NIH-funded research
Clinical First Approach: Every product is co-designed with practicing pelvic surgeons
Ethical Commitment: Never use animal testing - our 3D bioprinted human tissue models are PETA-approved
Global Recognition: 2024 Fast Company's Most Innovative Biotech Companies
Why We're Different

What Makes Us Unique

Our approach combines cutting-edge science with clinical excellence to deliver breakthrough solutions for women's health.

Science-Backed Innovation

Originating from 7 years of NIH-funded research at leading biomechanics laboratories

Clinical First Approach

Every product is co-designed with practicing pelvic surgeons for real-world effectiveness

Ethical Commitment

Never use animal testing - our 3D bioprinted human tissue models are PETA-approved

Global Recognition

2024 Fast Company's Most Innovative Biotech Companies, 2023 FDA Breakthrough Device Designation

Our Facilities

Global Infrastructure

State-of-the-art facilities across three continents to serve our global mission.

HQ & R&D

[City], [Country] (ISO Class 7 cleanrooms)

Clinical Training Center

[City] with VR surgical simulators

Global Manufacturing

FDA/MDR-certified facilities on 3 continents

Join Our Mission

We're Actively Seeking

Join our team in revolutionizing women's health through innovative biomaterials and clinical excellence.

Forward-thinking Clinicians

For our Global Surgeon Network

PhD Researchers

For our [Year] Fellowship Program

Impact Investors

For Series B funding